Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Galli

Showing results (51-60 of 217) with videos related to

Pageof 22
Sort By:
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|March 22, 2014
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patientsCaterina Sagnelli, Caterina Uberti-Foppa, Laura Galli, et al.
The Journal of Emergency Medicine|August 26, 2009
A qualification course in an international emergency medicine interventionScott G Weiner, Leon D Sanchez, Peter Rosen, et al.
International Journal of Antimicrobial Agents|May 26, 2020
Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimenMaria M Santoro, Chiara Fornabaio, Marina Malena, et al.
International Journal of Antimicrobial Agents|July 17, 2018
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimenNicola Gianotti, Laura Galli, Nadia Galizzi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2009
Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failureFrancesca Cossarini, Laura Galli, Caterina Sagnelli, et al.
Memorias Do Instituto Oswaldo Cruz|June 8, 2017
The use of circulating cathodic antigen rapid test and serology for diagnosis of active Schistosoma mansoni infection in migrants in Italy, a non-endemic country: a cross sectional studyLaura Infurnari, Laura Galli, Alba Bigoloni, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2020
HIV-DNA undetectability during chronic HIV infection: frequency and predictive factorsSilvia Nozza, Laura Galli, Nicola Gianotti, et al.
The Journal of Antimicrobial Chemotherapy|July 2, 2013
Plasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatmentVincenzo Spagnuolo, Deborah Cocorullo, Laura Galli, et al.
Medicine|June 4, 2016
Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or AbacavirNicola Gianotti, Laura Galli, Andrea Poli, et al.
Drug Design, Development and Therapy|April 15, 2024
Outcome of Darunavir-Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological FailureFrancesca Alberton, Laura Galli, Riccardo Lolatto, et al.
Pageof 22

Showing results (51-60 of 217) with videos related to

Sort By:
Pageof 22
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|March 22, 2014
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patientsCaterina Sagnelli, Caterina Uberti-Foppa, Laura Galli, et al.
The Journal of Emergency Medicine|August 26, 2009
A qualification course in an international emergency medicine interventionScott G Weiner, Leon D Sanchez, Peter Rosen, et al.
International Journal of Antimicrobial Agents|May 26, 2020
Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimenMaria M Santoro, Chiara Fornabaio, Marina Malena, et al.
International Journal of Antimicrobial Agents|July 17, 2018
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimenNicola Gianotti, Laura Galli, Nadia Galizzi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2009
Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failureFrancesca Cossarini, Laura Galli, Caterina Sagnelli, et al.
Memorias Do Instituto Oswaldo Cruz|June 8, 2017
The use of circulating cathodic antigen rapid test and serology for diagnosis of active Schistosoma mansoni infection in migrants in Italy, a non-endemic country: a cross sectional studyLaura Infurnari, Laura Galli, Alba Bigoloni, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 2020
HIV-DNA undetectability during chronic HIV infection: frequency and predictive factorsSilvia Nozza, Laura Galli, Nicola Gianotti, et al.
The Journal of Antimicrobial Chemotherapy|July 2, 2013
Plasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatmentVincenzo Spagnuolo, Deborah Cocorullo, Laura Galli, et al.
Medicine|June 4, 2016
Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or AbacavirNicola Gianotti, Laura Galli, Andrea Poli, et al.
Drug Design, Development and Therapy|April 15, 2024
Outcome of Darunavir-Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological FailureFrancesca Alberton, Laura Galli, Riccardo Lolatto, et al.
Pageof 22